LCN2 and esophageal squamous cell carcinoma: Elevated LCN2 expression has also been observed in multiple human cancers including breast, colorectal, pancreatic, ovarian, gastric, thyroid, ovarian, bladder, and kidney cancers, as well as glioma and esophageal squamous cell carcinoma (ESCC) [4–10].